Free Trial

Sherbrooke Park Advisers LLC Has $725,000 Holdings in EverQuote, Inc. (NASDAQ:EVER)

EverQuote logo with Finance background

Sherbrooke Park Advisers LLC grew its holdings in EverQuote, Inc. (NASDAQ:EVER - Free Report) by 94.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 36,282 shares of the company's stock after buying an additional 17,648 shares during the quarter. Sherbrooke Park Advisers LLC owned approximately 0.10% of EverQuote worth $725,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. R Squared Ltd bought a new stake in EverQuote during the 4th quarter worth about $34,000. Asset Management One Co. Ltd. lifted its position in shares of EverQuote by 80.4% during the fourth quarter. Asset Management One Co. Ltd. now owns 4,582 shares of the company's stock worth $90,000 after purchasing an additional 2,042 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of EverQuote during the fourth quarter valued at approximately $90,000. AlphaQuest LLC grew its stake in shares of EverQuote by 53.9% during the fourth quarter. AlphaQuest LLC now owns 7,704 shares of the company's stock valued at $154,000 after purchasing an additional 2,698 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in shares of EverQuote by 23.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 8,968 shares of the company's stock valued at $179,000 after purchasing an additional 1,724 shares in the last quarter. 91.54% of the stock is currently owned by institutional investors and hedge funds.

EverQuote Stock Performance

EVER traded down $1.04 during midday trading on Wednesday, reaching $22.61. 548,683 shares of the company were exchanged, compared to its average volume of 548,972. The stock has a market capitalization of $807.72 million, a P/E ratio of 66.50 and a beta of 0.45. EverQuote, Inc. has a one year low of $16.63 and a one year high of $30.03. The stock's 50-day simple moving average is $24.30 and its 200 day simple moving average is $21.66.

EverQuote (NASDAQ:EVER - Get Free Report) last announced its quarterly earnings results on Monday, February 24th. The company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.18. The business had revenue of $147.46 million for the quarter, compared to the consensus estimate of $133.83 million. EverQuote had a net margin of 3.31% and a return on equity of 13.94%. On average, research analysts anticipate that EverQuote, Inc. will post 0.72 earnings per share for the current year.

Insider Transactions at EverQuote

In related news, CTO David Brainard sold 6,609 shares of the firm's stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $21.49, for a total transaction of $142,027.41. Following the sale, the chief technology officer now owns 156,783 shares of the company's stock, valued at approximately $3,369,266.67. This trade represents a 4.04% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director David B. Blundin sold 77,600 shares of EverQuote stock in a transaction dated Friday, March 21st. The stock was sold at an average price of $28.67, for a total value of $2,224,792.00. Following the transaction, the director now owns 97,920 shares in the company, valued at approximately $2,807,366.40. This represents a 44.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 193,238 shares of company stock valued at $5,264,349 over the last three months. 29.79% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on EVER. JPMorgan Chase & Co. upped their price objective on EverQuote from $29.00 to $30.00 and gave the stock an "overweight" rating in a report on Tuesday, May 6th. Canaccord Genuity Group cut their price target on EverQuote from $35.00 to $30.00 and set a "buy" rating on the stock in a research note on Monday, February 24th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $38.00 price target on shares of EverQuote in a report on Tuesday, May 6th. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Buy" and an average price target of $32.50.

Check Out Our Latest Research Report on EverQuote

EverQuote Profile

(Free Report)

EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.

Featured Stories

Institutional Ownership by Quarter for EverQuote (NASDAQ:EVER)

Should You Invest $1,000 in EverQuote Right Now?

Before you consider EverQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.

While EverQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines